Solara Active Pharma Sciences Ltd

NSE: SOLARA · BSE: 541540 · Pharmaceuticals & Biotechnology · 28 announcements

Share price: ₹691.70
Market cap: ₹3,324 Cr
Revenue (annual): ₹1,369 Cr
Net profit (annual): ₹-7.41 Cr
P/E (TTM): -2052.0×Sector 47.4×
Promoter holding: 41.93%-0.07% QoQ
FII holding: 11.52%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Employee Stock Options 6 Other Announcement 4 Earnings Call 3 Management Change 2 Financial Results 2 Capital Structure Change 2 Board Meeting Date 2 Annual General Meeting 2 Results Update 1 Price Movement Clarification 1 Legal & Regulatory 1 Fund Raise 1 Business Update 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

28 Apr 2026 17:01 IST NSE

Business Update

Solara Active Pharma Sciences Business Update

Solara Active Pharma Sciences announced the successful closure of a US FDA inspection at its Puducherry Ibuprofen facility. The inspection, conducted in February 2026, concluded with a 'Voluntary Action Indicated' classification and issuance of an Establishment Inspection Report. The site remains in a state of cGMP compliance, supporting its global API manufacturing strategy.

Read the filing ↗